Published in Mol Imaging Biol on September 22, 2003
Cine CT for attenuation correction in cardiac PET/CT. J Nucl Med (2007) 1.35
PET/CT imaging: effect of respiratory motion on apparent myocardial uptake. J Nucl Cardiol (2006) 1.05
CT-based attenuation correction in (82)Rb-myocardial perfusion PET-CT: incidence of misalignment and effect on regional tracer distribution. Eur J Nucl Med Mol Imaging (2007) 1.03
Sources of attenuation-correction artefacts in cardiac PET/CT and SPECT/CT. Eur J Nucl Med Mol Imaging (2008) 0.98
Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Eur J Nucl Med Mol Imaging (2005) 0.90
Comparing approaches to correct for respiratory motion in NH3 PET-CT cardiac perfusion imaging. Nucl Med Commun (2013) 0.79
Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET. Eur J Nucl Med Mol Imaging (2007) 0.79
Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations. Cancer Imaging (2007) 0.77
Four-dimensional (4D) motion detection to correct respiratory effects in treatment response assessment using molecular imaging biomarkers. Technol Cancer Res Treat (2013) 0.75
Respiratory motion detection and correction in ECG-gated SPECT: a new approach. Korean J Radiol (2008) 0.75
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med (2008) 4.71
Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol (2004) 3.85
Towards real-time intravascular endoscopic magnetic resonance imaging. JACC Cardiovasc Imaging (2010) 2.96
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy. J Clin Oncol (2009) 2.67
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med (2007) 2.49
Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med (2007) 2.08
Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson (2008) 2.08
Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology (2010) 1.98
Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging. Eur Heart J (2004) 1.85
Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia (2005) 1.78
Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol (2004) 1.71
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med (2003) 1.64
Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies. Radiology (2008) 1.56
Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging (2004) 1.54
Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med (2011) 1.45
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood (2004) 1.35
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging (2008) 1.34
Real-time imaging of regional myocardial function using fast-SENC. Magn Reson Med (2006) 1.31
Three-dimensional imaging-based radiobiological dosimetry. Semin Nucl Med (2008) 1.31
Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med (2002) 1.30
Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology (2003) 1.28
Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med (2002) 1.26
F-18 FDG PET of foreign body granuloma: pathologic correlation with imaging features in 3 cases. Clin Nucl Med (2010) 1.25
Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mol Imaging (2003) 1.25
Cardiac magnetic resonance imaging in small rodents using clinical 1.5 T and 3.0 T scanners. Methods (2007) 1.23
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol (2011) 1.19
Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation. J Nucl Med (2012) 1.17
Synthesis of magnetic resonance-, X-ray- and ultrasound-visible alginate microcapsules for immunoisolation and noninvasive imaging of cellular therapeutics. Nat Protoc (2011) 1.17
Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. Radiology (2005) 1.17
Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol (2006) 1.16
Normal uptake of 18F-FDG in the testis: an assessment by PET/CT. Ann Nucl Med (2007) 1.16
Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer Res (2003) 1.16
Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging (2011) 1.15
Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother Oncol (2010) 1.12
The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope (2005) 1.12
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer. Breast Cancer Res Treat (2011) 1.10
Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality". Ann Nucl Med (2003) 1.09
Suture granuloma showing false-positive finding on PET/CT after head and neck cancer surgery. Auris Nasus Larynx (2011) 1.09
Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer. Cancer Invest (2007) 1.09
FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med (2011) 1.09
Distribution of cell-free and cell-associated HIV surrogates in the female genital tract after simulated vaginal intercourse. J Infect Dis (2012) 1.07
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab (2004) 1.02
The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.01
Late systolic onset of regional LV relaxation demonstrated in three-dimensional space by MRI tissue tagging. Am J Physiol Heart Circ Physiol (2004) 1.01
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann Nucl Med (2004) 1.01
Current perspectives on imaging cardiac stem cell therapy. J Nucl Med (2010) 1.00
Tuberculous lymphadenitis as a cause of obstructive jaundice: report of a case. Surg Today (2003) 1.00
The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J (2005) 1.00
MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging (2007) 0.99
The potential clinical value of FDG-PET for recurrent renal cell carcinoma. Eur J Radiol (2009) 0.98
Recent advances in small-animal cardiovascular imaging. J Nucl Med (2009) 0.97
The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes. J Immunol (2008) 0.96
Performance characteristics of a new 3-dimensional continuous-emission and spiral-transmission high-sensitivity and high-resolution PET camera evaluated with the NEMA NU 2-2001 standard. J Nucl Med (2006) 0.96
Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med (2003) 0.96
Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. Methods Mol Biol (2010) 0.95
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia. Nucl Med Commun (2015) 0.94
18F-fluorobenzyl triphenyl phosphonium: a noninvasive sensor of brown adipose tissue thermogenesis. J Nucl Med (2011) 0.93
Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer. Clin Cancer Res (2012) 0.93
MRI dynamic range and its compatibility with signal transmission media. J Magn Reson (2009) 0.92
Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model. Acad Radiol (2005) 0.92
Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent. Magn Reson Med (2006) 0.91
Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer. Eur J Nucl Med Mol Imaging (2012) 0.91
Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Ann Nucl Med (2006) 0.90
Capsule endoscopy: is there a role for nurses as physician extenders? Gastroenterol Nurs (2007) 0.90
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer. J Hepatobiliary Pancreat Sci (2010) 0.90
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging (2003) 0.89
MRI of the female pelvis at 3T compared to 1.5T: evaluation on high-resolution T2-weighted and HASTE images. J Magn Reson Imaging (2007) 0.89
High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): comparison of 3T vs. 1.5T. Eur J Radiol (2008) 0.89
Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol (2004) 0.88
Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model. Radiology (2008) 0.88
Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification. Neoplasia (2003) 0.88
Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors. Ann Nucl Med (2008) 0.88
FDG-PET/CT assessment of misty mesentery: feasibility for distinguishing viable mesenteric malignancy from stable conditions. Eur J Radiol (2013) 0.88
Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy. Expert Rev Cardiovasc Ther (2010) 0.88
Diffuse homogeneous bone marrow uptake of FDG in patients with acute lymphoblastic leukemia. Clin Nucl Med (2013) 0.87
Diagnostic performance of CT, PET, side-by-side, and fused image interpretations for restaging of non-Hodgkin lymphoma. Ann Nucl Med (2007) 0.87
Microencapsulated cell tracking. NMR Biomed (2012) 0.86
High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Reson Imaging (2008) 0.86
Synthesis and biodistribution of [11C]adenosine 5'-monophosphate ([11C]AMP). Mol Imaging Biol (2005) 0.86
FDG-PET/CT for diagnosis of primary ovarian cancer. Nucl Med Commun (2011) 0.85
Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med (2003) 0.85
Hind limb ischemia in rabbit model: T2-prepared versus time-of-flight MR angiography at 3 T. Radiology (2007) 0.85
Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET. Eur J Nucl Med Mol Imaging (2002) 0.85
Diffusion tensor imaging of kidneys with respiratory triggering: optimization of parameters to demonstrate anisotropic structures on fraction anisotropy maps. J Magn Reson Imaging (2009) 0.85
Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging? Ann Nucl Med (2009) 0.84
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. AJR Am J Roentgenol (2014) 0.84
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence. Eur J Nucl Med Mol Imaging (2010) 0.84
(11)C-Methionine PET/CT for multiple myeloma. Int J Hematol (2010) 0.83
Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma. Ann Surg Oncol (2011) 0.83
18F-FDG uptake in intraductal tubulopapillary neoplasm of the pancreas. Clin Nucl Med (2014) 0.83
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Int J Oncol (2009) 0.83
A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck. Clin Cancer Res (2012) 0.83
Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine. Radiology (2002) 0.83
Diffusion tensor MRI of the kidney at 3.0 and 1.5 Tesla. Acta Radiol (2010) 0.83
MR-guided portal vein delivery and monitoring of magnetocapsules: assessment of physiologic effects on the liver. J Vasc Interv Radiol (2011) 0.83